Alvotech (ALVO) vs Prestige Consumer Healthcare Inc. (PBH)
- Alvotech ALVO 5.00 −5.84%
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
Alvotech and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Prestige Consumer Healthcare Inc. is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.9×. Alvotech grew revenue faster over the last twelve months: 364.3% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs −101.1%) and the higher return on invested capital (4.70% vs 0.00%). Across the 17 metrics below, Prestige Consumer Healthcare Inc. leads on 14 and Alvotech on 3.
Valuation
Profitability
| Metric | ALVO | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 53.53% | 53.94% |
| Operating margin | (42.43%) | 26.26% | 0.00% |
| Net margin | (101.05%) | 15.57% | 0.00% |
| Free cash flow margin | 0.00% | 21.30% | 0.00% |
| Return on equity | 0.00% | 9.12% | (0.40%) |
| Return on assets | 0.00% | 4.30% | (3.32%) |
| Return on invested capital | 0.00% | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack